Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News Dominican Republic.
Press releases published on July 28, 2025
EIN Presswire Debuts Podcast with PR Insider Sherrie Handrinos on the Power of Influencer Marketing
EIN Presswire
·
July 28, 2025
“Heard on the Streets” podcast explores how brands are cashing in on social media strategy WASHINGTON , DC, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- EIN Presswire has launched its first audio podcast on Substack, and it’s diving into one of …
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
GlobeNewswire
·
July 28, 2025
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant …
North Park Nursing Student Receives Prestigious Schweitzer Fellowship
GlobeNewswire
·
July 28, 2025
Chicago, July 28, 2025 (GLOBE NEWSWIRE) -- Victoria Roehl, a student in the Master of Nursing Leadership program at North Park University (NPU), has been named a 2025–26 Schweitzer Fellow, a prestigious honor given to graduate students to lead innovative, …
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger - CrazyBulk
GlobeNewswire
·
July 28, 2025
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025 In the evolving world of performance fitness, …
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire
·
July 28, 2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company …
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
GlobeNewswire
·
July 28, 2025
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and …
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen …
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
GlobeNewswire
·
July 28, 2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique …
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with …
Abivax Announces Closing of $747.5 Million Public Offering
GlobeNewswire
·
July 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 28, 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support …
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine
GlobeNewswire
·
July 28, 2025
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgique – 28 juillet 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société …
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
GlobeNewswire
·
July 28, 2025
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 PM ET featuring Anthony Langone, MD ( …
AVITA Medical to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 28, 2025
VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second …
Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
GlobeNewswire
·
July 28, 2025
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced proposed underwritten public offerings of $150,000, …
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
July 28, 2025
MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class-leading Phase 1 results including 8.4% five …
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Legal Steroids for Muscle Endurance A Guide in 2025 For Bodybuilders Muscle Growth
GlobeNewswire
·
July 28, 2025
Los Angeles, CA, July 28, 2025 (GLOBE NEWSWIRE) -- For beginners looking to build muscle fast in 2025, achieving rapid growth involves more than just lifting weights. A proven combination of the right workout strategies, balanced nutrition, and effective …
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show
GlobeNewswire
·
July 28, 2025
Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Key Takeaways Findings from breakthrough approach to early detection for Alzheimer’s disease (AD) has the …
Next-Gen Batteries Set for 28.5% CAGR Through 2029
GlobeNewswire
·
July 28, 2025
Boston, July 28, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Next-Generation Advanced Batteries: Global Markets” is projected to grow from $1.5 billion in 2024 to $5.3 billion by the end of 2029, at a compound annual growth …